Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System
Authors:
Open Access
- 20 September 2017
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 4, 57
Abstract
Coronary artery disease (CAD) has a complex etiology involving numerous environmental and genetic factors of disease risk. To date, the genetic 9p21 locus represents the most robust genetic finding for prevalent and incident CAD. However, limited information is available on the genetic background of the severity and distribution of CAD. CAD manifests itself as stable CAD or acute coronary syndrome. The Gensini score quantifies the extent CAD but requires coronary angiography. Here, we aimed to identify novel genetic variants associated with Gensini score severity and distribution of CAD. A two-stage approach including a discovery and a replication stage was used to assess genetic variants. In the discovery phase, a meta-analysis of genome-wide association data of 4,930 CAD-subjects assessed by the Gensini score was performed. Selected single nucleotide polymorphisms (SNPs) were replicated in 2,283 CAD-subjects by de novo genotyping. We identified genetic loci located on chromosome 2 and 9 to be associated with Gensini score severity and distribution of CAD in the discovery stage. Although the loci on chromosome 2 could not be replicated in the second stage, the known CAD-locus on chromosome 9p21, represented by rs133349, was identified and, thus, was confirmed as risk locus for CAD severity.Keywords
This publication has 21 references indexed in Scilit:
- Genetics of Coronary Artery DiseaseCirculation Research, 2016
- A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery diseaseNature Genetics, 2015
- 2013 ESC guidelines on the management of stable coronary artery diseaseEuropean Heart Journal, 2013
- Genetics of Coronary Artery Disease and Myocardial Infarction - 2013Current Cardiology Reports, 2013
- Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk IndividualsJAMA, 2012
- Rationale and Design of the Leipzig (LIFE) Heart Study: Phenotyping and Cardiovascular Characteristics of Patients with Coronary Artery DiseasePLOS ONE, 2011
- Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2003
- Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular diseasePharmacogenomics, 2001
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- A more meaningful scoring system for determining the severity of coronary heart diseaseThe American Journal of Cardiology, 1983